This Week: Energy and Commerce Health Subcommittee Explores Post-Acute Bundling...CMS Releases First-ever Hospital Compare Star Ratings...Fiscal Year 2016 Proposed Inpatient and Long-term Care Hospital Policy and Payment Changes
1. Congress
House of Representatives
- Energy and Commerce Health Subcommittee Explores Post-Acute Bundling
- House W&M Health Subcommittee Holds Hearing on ACA Individual and Employer Mandates
- Upcoming: Energy and Commerce Oversight Hearing on Opioid Abuse
Senate
- Senate Approves, President Enacts Bipartisan Medicare Physician Payment Fix
- Upcoming: Senate Commerce Committee to Host Hearing on Expanding Progress on Telehealth
- Upcoming: Senate Finance Health Subcommittee to Hold Hearing on Impacts of Medical Device Tax
- HHS-OIG Accepts Request to Investigate Generic Drug Pricing
2. Administration
- CMS to Award $201 Million over Three Years in Navigator Grants
- HHS: $1 Million in New Grants Available to Help Improve Health IT Sharing
- FDA Releases Guidance on Striking Median between Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval
- CMS Releases First-ever Hospital Compare Star Ratings
- Wachino Named as Permanent Chief Medicaid Official
3. State Activities
4. Regulations Open for Comment
- Fiscal Year 2016 Proposed Inpatient and Long-term Care Hospital Policy and Payment Changes
- Proposed FY 2016 Payment and Policy Changes for Medicare Skilled Nursing Facilities (SNF)
- CMS Proposes Mental Health Parity for Medicaid and CHIP in New Rule
- FDA Assessing the Center of Drug Evaluation and Research's Safety-Related Regulatory Science Needs and Identifying Priorities
- National Coverage Determinations Proposed for Removal
- HHS Releases Proposed Rules on EHR Incentive Programs and Health IT Certification Criteria
- Use of an Electronic Informed Consent in Clinical Investigations: Questions and Answers; Draft Guidance for Industry, Clinical Investigators and Institutional Review Boards
- FDA: Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling
- Compounding of Human Drug Products Under the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket
- FDA Solicits Comments on New Methodologies for Generic Drug Clinical Studies
- FDA Reopens Comment Period for Generic Drug Labeling Rule
- FDA Releases Five Draft Guidance Documents on Drug Compounding
5. Reports
- Office of the National Coordinator for Health Information Technology (ONC): Report on Health Information Blocking
- HHS Report: Medicare Spending Was $316 Billion Lower than Average Growth Rate Spending Between 2009 and 2013
- CDC/USDA Report Finds Increase in E-Cigarette Use Among Teens
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
